Kaplan–Meier survival curve analysis demonstrated that HCC patients with low LZTS2 expression levels had a shorter overall survival than patients with high LZTS2 expression levels (P = 0.0043) (Fig. 1d), suggesting that low LZTS2 expression predicts poor prognosis in HCC. This evidence concerns the gene LZTS2 and hepatocellular carcinoma.